Anand Bhaskar

Officer at REATA PHARMACEUTICALS INC

Sold, on record
$554k
Dollars the filings state
Form 4 sales
6
Latest Sep 5, 2023
Form 144 notices
6
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale REATA PHARMACEUTICALS INCNo plan
    May 16, 2023 2023

    Sold 1,086 shares at $85.37 ($93k)

    Anand Bhaskar, SVP, Chief Accounting Officer

    No 10b5-1 planSold 4.1% of holdings ($2.3M position)25,679 shares leftFollows a Form 144Filing

  2. 2 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Jun 14, 2023 +29 days

    Filed to sell 2,343 shares ($239k)

    Anand Bhaskar, Officer

    No 10b5-1 plan2.9x usual sizeFiling

  3. 3 Form 4 sale REATA PHARMACEUTICALS INCNo plan
    Jun 14, 2023 same day

    Sold 2,343 shares at $102.11 ($239k)

    Anand Bhaskar, SVP, Chief Accounting Officer

    No 10b5-1 planSold 8.6% of holdings ($2.8M position)24,898 shares left2.9x usual sizeFollows a Form 144Filing

  4. 4 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Aug 15, 2023 +62 days

    Filed to sell 193 shares ($33k)

    Anand Bhaskar, Officer

    No 10b5-1 plan0.2x usual sizeFiling

  5. 5 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Aug 16, 2023 +1 day

    Filed to sell 210 shares ($35k)

    Anand Bhaskar, Officer

    No 10b5-1 plan0.2x usual sizeFiling

  6. 6 Form 4 sale REATA PHARMACEUTICALS INCNo plan
    Aug 16, 2023 same day

    Sold 403 shares at $168.73 ($68k)

    Anand Bhaskar, SVP, Chief Accounting Officer

    No 10b5-1 planSold 1.6% of holdings ($4.2M position)24,495 shares left0.4x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Sep 5, 2023 +20 days

    Filed to sell 406 shares ($69k)

    Anand Bhaskar, Officer

    No 10b5-1 plan0.5x usual sizeFiling

  8. 8 Form 4 sale REATA PHARMACEUTICALS INCNo plan
    Sep 5, 2023 same day

    Sold 406 shares at $169.20 ($69k)

    Anand Bhaskar, SVP, Chief Accounting Officer

    No 10b5-1 planSold 1.7% of holdings ($4.1M position)24,089 shares left0.5x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (12)

Form 144 notices and Form 4 sales by Anand Bhaskar
Source
Sep 5, 2023Sep 7, 2023REATA PHARMACEUTICALS INCSVP, Chief Accounting OfficerForm 4 sale406$69k1.7%No planSEC
Sep 5, 2023Sep 5, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice406$69kNoticeSEC
Aug 16, 2023Aug 17, 2023REATA PHARMACEUTICALS INCSVP, Chief Accounting OfficerForm 4 sale403$68k1.6%No planSEC
Aug 16, 2023Aug 16, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice210$35kNoticeSEC
Aug 15, 2023Aug 15, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice193$33kNoticeSEC
Jun 14, 2023Jun 16, 2023REATA PHARMACEUTICALS INCSVP, Chief Accounting OfficerForm 4 sale2,343$239k8.6%No planSEC
Jun 14, 2023Jun 14, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice2,343$239kNoticeSEC
May 16, 2023May 17, 2023REATA PHARMACEUTICALS INCSVP, Chief Accounting OfficerForm 4 sale1,086$93k4.1%No planSEC
May 16, 2023May 16, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice136$11kNoticeSEC
May 15, 2023May 15, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice950$82kNoticeSEC
Mar 7, 2023Mar 8, 2023REATA PHARMACEUTICALS INCSVP, Chief Accounting OfficerForm 4 sale165$14k0.6%Plan not statedSEC
Mar 3, 2023Mar 6, 2023REATA PHARMACEUTICALS INCSVP, Chief Accounting OfficerForm 4 sale820$72k3.0%Plan not statedSEC